Hematopoietic contribution to skeletal muscle regeneration by myelomonocytic precursors

Adult bone marrow-derived cells can participate in muscle regeneration after bone marrow transplantation. In recent studies a single hematopoietic stem cell (HSC) was shown to give rise to cells that not only reconstituted all of the lineages of the blood, but also contributed to mature muscle fibers. However, the relevant HSC derivative with this potential has not yet been definitively identified. Here we use fluorescence-activated cell sorter-based protocols to test distinct hematopoietic fractions and show that only fractions containing c-kit(+) immature myelomonocytic precursors are capable of contributing to muscle fibers after i.m. injection. Although these cells belong to the myeloid lineage, they do not include mature CD11b(+) myelomonocytic cells, such as macrophages. Of the four sources of mature macrophages tested that were derived either from monocytic culture, bone marrow, peripheral blood after granulocyte colony-stimulating factor mobilization, or injured muscle, none contributed to muscle. In addition, after transplantation of bone marrow isolated from CD11b-Cre-transgenic mice into the Cre-reporter strain (Z/EG), no GFP myofibers were detected, demonstrating that macrophages expressing CD11b do not fuse with myofibers. Irrespective of the underlying mechanisms, these data suggest that the HSC derivatives that integrate into regenerating muscle fibers exist in the pool of hematopoietic cells known as myelomonocytic progenitors.     

Food Insecurity Screening in Pediatric Clinical Settings: A Caregivers’ Perspective

Maternal and Child Health Journal - Food insecurity (FI) has serious academic, social, and physical health consequences for children. A recent clinical recommendation suggests FI screening during...     

Psychometric discrimination of moderate senile dementia of the Alzheimer type.

A brief psychometric battery was used to differentiate a sample of 56 individuals classified as having mild senile dementia of the Alzheimer type (SDAT) from 38 individuals with moderate SDAT. Using discriminant analysis techniques, a modest differentiation was obtained. It was noted that specific ability domains, namely, short-term recognition memory, visuospatial reasoning, and verbal ability, contributed to the discriminant function. Although the same domains have been found to differentiate SDAT at earlier stages, individual tests varied in the current sample as a function of marked decrements in ability levels at this advanced stage of the disease. The results suggest that the effectiveness of specific psychometrics for differentiating individuals with SDAT may vary as a function of relative disease stage.     

Auto-anti-A1 antibody in a patient with metastatic adenocarcinoma

An autoantibody was found on the red cells of a patient who had never been transfused previously, but was ill with metastatic adenocarcinoma. The patient's blood group was A1. In addition, the patient's serum and the eluate from the patient's red cells agglutinated A1 but not A2, B, and O red cells. This auto-A1 antibody was reactive at a wide thermal range and was inactivated by dithiothreitol, suggesting the presence of an IgM immunoglobulin. Moreover, the antibody was not associated with a hemolytic anemia.     

Predictive value of the Boston Naming Test in mild senile dementia of the Alzheimer type

The prognostic implications of anomia were examined in a group of subjects with mild senile dementia of the Alzheimer type. Anomia was found to correlate with a more rapidly progressive course of illness. A subject's age did not account for the degree of anomia. Duration of illness was not correlated with the degree of anomia or with severity of dementia. The presence of anomia in a subject with mild senile dementia of the Alzheimer type appears to indicate a more rapidly progressive course.     

Aphasia in senile dementia of the Alzheimer type

We assessed language function, using a brief clinical Aphasia Battery and psychometric measures, in 150 subjects with senile dementia of the Alzheimer type (SDAT) and 83 elderly controls. Aphasia occurred only in demented subjects, and its prevalence increased with severity of dementia. Aphasia in mildly demented subjects was associated with both an earlier age of onset and more rapid progression of SDAT than in similarly demented nonaphasics. Language dysfunction in SDAT subjects was characterized by early decline in measures of comprehension and written expression, whereas other components, including oral naming, were less profoundly affected. Performance on the verbal psychometric measures, the Sentence Repetition and the Token tests, correlated strongly with Aphasia Battery scores and declined only minimally in nonaphasics, despite increasing dementia. We conclude that aphasia is a common feature of SDAT subjects and identifies a subgroup with more rapid progression of dementia. Furthermore, it represents language-specific dysfunction beyond the global cognitive impairment of SDAT.